🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This project is a prospective, multi-center, multi-cohort exploratory clini...
Status
Recruiting
Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Start Date
2025-05-22
Trial ID
NCT06893887
To observe the efficacy and safety of adebelizumab combined with chemothera...
Status
Recruiting
Location
The First Affiliated Hospital of Shandong First Medical University
Start Date
2023-10-30
Trial ID
NCT06125041
Treatments Being Tested
This study aims to evaluate the efficacy and safety of neoadjuvant trastuzu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07624201
Treatments Being Tested
To observe and evaluate the efficacy and safety of adebrelimab combination ...
Status
Recruiting
Location
Tianjin Cancer Institute and Hospital
Start Date
2024-07-01
Trial ID
NCT06506292
Treatments Being Tested
Evaluating the efficacy and safety of PD-L1 (Programmed Death-L1)antibody c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10
Trial ID
NCT06599775
Treatments Being Tested
This study aimed to evaluate the use of SHR-A1811 in HER2-expression Advanc...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2023-03-31
Trial ID
NCT05769010
Treatments Being Tested
Immunotherapy combined with chemotherapy has emerged as the standard of car...
Status
Recruiting
Location
Peking University Cancer Hospital and Institute
Start Date
2025-01-07
Trial ID
NCT06768307
Treatments Being Tested
This study is an open, single-arm, single-center phase II clinical study, w...
Status
Not Yet Recruiting
Location
Peking university cancer hospital
Start Date
2025-06-01
Trial ID
NCT07004712
Treatments Being Tested
This study is a randomized, open-label, controlled, multicenter Phase III c...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2025-10-22
Trial ID
NCT07170995
This study is an open-label, multicenter phase II clinical trial of adebeli...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2026-08
Trial ID
NCT07704645